世界中医药
文章摘要
引用本文:贡桂英,刘霞,马建红.中西医结合治疗慢性乙型重型肝炎43例临床观察[J].世界中医药,2009,4(4):.  
中西医结合治疗慢性乙型重型肝炎43例临床观察
Clinical Observation of 43 Cases of Chronic Severe Hepatitis B Treated by Integrated Chinese and Western Medicine
投稿时间:2008-10-09  
DOI:
中文关键词:  中西医结合  重型肝炎
English Keywords:integrated Chinese and western medicine  severe hepatitis
基金项目:
作者单位
贡桂英,刘霞,马建红 河北中医肝病医院河北省石家庄市正定城东街6号050800 
摘要点击次数: 1281
全文下载次数: 1357
中文摘要:
      目的:观察中西医结合治疗慢性乙型重型肝炎的临床疗效。方法:将86例慢性乙型重型肝炎患者随机分为治疗组43例,对照组43例。治疗组采用西医常规治疗,加上中医中药辨证治疗。对照组仅予以西医常规治疗。2组治疗前后比较临床存活率和病死率,并观察肝功能及凝血功能变化。结果:治疗结束后,治疗组存活率72.1%,疗效优于对照组的55.9%,且治疗组ALT、TBil、Alb、PTA等实验室指标的定量检测均较对照组有明显改善(P<0.05);同时治疗组治疗前后其肝功能、凝血功能也有显著改善(P<0.05)。结论:中西医结合治疗慢性乙型重型肝炎有较好疗效。
English Summary:
      To observe the effect of integrated Chinese and western medicine on chronic severe hepatitis B.Methods:Eight-six cases were divided at random to treat group (n=43), who received a combined regime of routine western treatment and Chinese formulas, and control group (n=43) who were given routine western treatments only. Survival rate, mortality rate, liver function and PTA were measured before and after treatment. Results:Survival rate for the treat group was 72.1% compared with 55.9% for the control group. For the treat group, ALT, TBil, Alb, PTA were significantly lowered and liver functions improved compared with those of the control group (P<0.05).Conclusion:Integrated Chinese and western medicine is effective for treating Chronic severe hepatitis B.
查看全文  查看/发表评论  下载PDF阅读器